What You Should Know:
- OncoHost, a company pioneering personalized medicine approaches for better patient outcomes, announced a collaborative research study with Dana-Farber Cancer Institute, a leading cancer treatment and research center.
- The project aims to identify biomarkers in blood for renal cell carcinoma (RCC), a type of kidney cancer.
The Challenge of Personalized Treatment for RCC:
While immune-checkpoint inhibitor (ICI) therapy has revolutionized RCC treatment,
Read More
Mayo Clinic Taps UltraSight to Advance AI-Powered Ultrasound for Cardiac Care
What You Should Know:
- UltraSight, a leader in transforming cardiac imaging with artificial intelligence, announced a new collaboration with Mayo Clinic, a world-renowned medical center.
- UltraSight and Mayo Clinic will work together to develop algorithms for analyzing and interpreting cardiac ultrasound images captured using point-of-care ultrasound (PoCUS) devices. This collaboration seeks to create a comprehensive solution that provides decision support for healthcare
Read More
Deloitte Acquires End Point’s Disease Surveillance Business, CasePointer
What You Should Know:
- Deloitte announced today the acquisition of substantially all assets of End Point's industry-leading disease surveillance business, CasePointer. This strategic move strengthens Deloitte's Public Health Transformation team with experienced professionals and enhances its capabilities in supporting public health agencies.
- Deloitte is only acquiring assets related to End Point's CasePointer business. End Point will retain all other aspects of its
Read More
Generation Lab Launches Platform to Measure Aging Speed and Extend Lifespan
What You Should Know:
- Generation Lab, a pioneer in the field of longevity, has announced the general availability of its revolutionary platform designed to measurably extend the human lifespan.
- The first-of-its-kind offering provides a comprehensive approach to understanding and managing the aging process, empowering individuals to take control of their health and well-being.
Beyond the Hype: Measuring Aging Effectiveness
While interest in longevity is growing, the
Read More
Hospitals See Strong Financial Performance in April, Despite Rising Expenses
What You Should Know:
- U.S. hospitals and health systems continued to experience positive financial performance in April, with patient demand and revenues rising for the 12th consecutive month, according to new data from Strata Decision Technology.
- While hospitals and health systems experienced positive financial performance in April, rising expenses remain a concern. Continued monitoring of these trends will be crucial for understanding the overall health of the healthcare
Read More
J.D. Power Study Reveals Growing Gap in Commercial Health Plan Satisfaction
What You Should Know:
- The J.D. Power 2024 U.S. Commercial Member Health Plan Study, released, highlights a significant gap in customer satisfaction between different health insurance providers. While overall satisfaction has increased slightly, the difference between the top and bottom-ranked plans has widened significantly.
- The study, now in its 18th year, surveyed nearly 30,000 commercial health plan members across 22 regions. It measures satisfaction based on eight core
Read More
Weave Bio Launches for AI-Powered Drug Development, Secures $10M
What You Should Know:
- Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic Ventures.
- AutoIND marks a significant advancement in drug development by automating and accelerating the preparation, writing, and review process for Investigational New Drug (IND) applications.
Automating the IND Process: A Game-Changer for Drug
Read More
Virtual Therapeutics Acquires Akili: Stock to Go Private After Merger
What You Should Know:
- Virtual Therapeutics, a leader in using engaging games for mental health treatment, announced today it will acquire Akili, Inc. (Nasdaq: AKLI), a prominent digital therapeutics company. This merger creates a diversified powerhouse in the digital health industry.
- Once the acquisition is complete, Akili's common stock will be delisted from all public stock exchanges. The combined entity's focus on mental health and broader digital therapeutics solutions
Read More
Medable Partners with Masimo to Bring Wearable Devices to Clinical Research, Capturing Better Data
What You Should Know:
- Medable Inc., a leader in modern clinical trial technology, has announced a groundbreaking partnership with Masimo (NASDAQ: MASI) to integrate medical-grade wearable devices into clinical research. This collaboration aims to streamline patient participation and enhance data collection for clinical trials.
- By offering a patient-centric approach and fostering richer data collection, this collaboration holds promise for faster drug development, improved patient
Read More
New AI Test Aims to Improve Breast Cancer Recurrence Prediction: COTA, PreciseDx, and Baptist Health South Florida Collaborate
What You Should Know:
- A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for faster, more accurate, and more affordable risk prediction compared to current methods.
- By utilizing AI technology, PreciseBreast™ has the potential to offer patients a faster, more accurate, and more affordable way to assess their risk of
Read More
